244 related articles for article (PubMed ID: 23880848)
1. Sarcosine as a potential prostate cancer biomarker--a review.
Cernei N; Heger Z; Gumulec J; Zitka O; Masarik M; Babula P; Eckschlager T; Stiborova M; Kizek R; Adam V
Int J Mol Sci; 2013 Jul; 14(7):13893-908. PubMed ID: 23880848
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.
Sreekumar A; Poisson LM; Rajendiran TM; Khan AP; Cao Q; Yu J; Laxman B; Mehra R; Lonigro RJ; Li Y; Nyati MK; Ahsan A; Kalyana-Sundaram S; Han B; Cao X; Byun J; Omenn GS; Ghosh D; Pennathur S; Alexander DC; Berger A; Shuster JR; Wei JT; Varambally S; Beecher C; Chinnaiyan AM
Nature; 2009 Feb; 457(7231):910-4. PubMed ID: 19212411
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the metabolome suggests a major potential role of sarcosine in the progression of cancer of the prostate].
Darbon JM
Bull Cancer; 2009 Apr; 96(4):355-6. PubMed ID: 19562840
[No Abstract] [Full Text] [Related]
4. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
[TBL] [Abstract][Full Text] [Related]
5. Is sarcosine a biomarker for prostate cancer?
Issaq HJ; Veenstra TD
J Sep Sci; 2011 Dec; 34(24):3619-21. PubMed ID: 22009695
[TBL] [Abstract][Full Text] [Related]
6. Plasma sarcosine does not distinguish early and advanced stages of prostate cancer.
Bohm L; Serafin AM; Fernandez P; Van der Watt G; Bouic PJ; Harvey J
S Afr Med J; 2012 Jun; 102(8):677-9. PubMed ID: 22831945
[TBL] [Abstract][Full Text] [Related]
7. Sarcosine Up-Regulates Expression of Genes Involved in Cell Cycle Progression of Metastatic Models of Prostate Cancer.
Heger Z; Merlos Rodrigo MA; Michalek P; Polanska H; Masarik M; Vit V; Plevova M; Pacik D; Eckschlager T; Stiborova M; Adam V
PLoS One; 2016; 11(11):e0165830. PubMed ID: 27824899
[TBL] [Abstract][Full Text] [Related]
8. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
de Vogel S; Ulvik A; Meyer K; Ueland PM; Nygård O; Vollset SE; Tell GS; Gregory JF; Tretli S; Bjørge T
Int J Cancer; 2014 Jan; 134(1):197-206. PubMed ID: 23797698
[TBL] [Abstract][Full Text] [Related]
9. The role of sarcosine metabolism in prostate cancer progression.
Khan AP; Rajendiran TM; Ateeq B; Asangani IA; Athanikar JN; Yocum AK; Mehra R; Siddiqui J; Palapattu G; Wei JT; Michailidis G; Sreekumar A; Chinnaiyan AM
Neoplasia; 2013 May; 15(5):491-501. PubMed ID: 23633921
[TBL] [Abstract][Full Text] [Related]
10. [Glycine-N-methyltransferase and Malignant Diseases of the Prostate].
Heger Z; Eckschlager T; Stiborová M; Adam V
Klin Onkol; 2016; 29(5):331-335. PubMed ID: 27739310
[TBL] [Abstract][Full Text] [Related]
11. On-line determination of sarcosine in biological fluids utilizing dummy molecularly imprinted polymers in microextraction by packed sorbent.
Moein MM; Abdel-Rehim A; Abdel-Rehim M
J Sep Sci; 2015 Mar; 38(5):788-95. PubMed ID: 25545817
[TBL] [Abstract][Full Text] [Related]
12. A case control study of sarcosine as an early prostate cancer detection biomarker.
Ankerst DP; Liss M; Zapata D; Hoefler J; Thompson IM; Leach RJ
BMC Urol; 2015 Oct; 15():99. PubMed ID: 26429735
[TBL] [Abstract][Full Text] [Related]
13. A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer.
Cao DL; Ye DW; Zhang HL; Zhu Y; Wang YX; Yao XD
Prostate; 2011 May; 71(7):700-10. PubMed ID: 20957673
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Advances in biomarkers for the early diagnosis of prostate cancer.
Cao DL; Yao XD
Chin J Cancer; 2010 Feb; 29(2):229-33. PubMed ID: 20109357
[TBL] [Abstract][Full Text] [Related]
16. Plasma Sarcosine Measured by Gas Chromatography-Mass Spectrometry Distinguishes Prostatic Intraepithelial Neoplasia and Prostate Cancer from Benign Prostate Hyperplasia.
Markin PA; Brito A; Moskaleva N; Fodor M; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; Lyundup AV; Appolonova SA
Lab Med; 2020 Nov; 51(6):566-573. PubMed ID: 32161964
[TBL] [Abstract][Full Text] [Related]
17. Sarcosine influences apoptosis and growth of prostate cells via cell-type specific regulation of distinct sets of genes.
Rodrigo MAM; Strmiska V; Horackova E; Buchtelova H; Michalek P; Stiborova M; Eckschlager T; Adam V; Heger Z
Prostate; 2018 Feb; 78(2):104-112. PubMed ID: 29105933
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Evaluation of
Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
[TBL] [Abstract][Full Text] [Related]
19. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
20. Novel biomarkers and therapeutic targets for prostate cancer.
Williams RM; Naz RK
Front Biosci (Schol Ed); 2010 Jan; 2(2):677-84. PubMed ID: 20036976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
